Mesoporous Polydopamine Nano-Bowls Demonstrate a High Entrapment Efficiency and pH-Responsive Release of Paclitaxel for Suppressing A549 Lung Cancer Cell Proliferation In Vitro
Open Access
- 1 December 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (12) , 1536
Abstract
Background: The effectiveness of paclitaxel (PTX) in treating non-small-cell lung carcinoma (NSCLC) is restricted by its poor pharmacokinetic profile and side effects. This limitation stems from the lack of a suitable delivery vector to efficiently target cancer cells. Therefore, there is a critical need to develop an efficient carrier for the optimised delivery of PTX in NSCLC therapy. Methods: The present study describes the fabrication of mesoporous polydopamine (mPDA) nano-bowls via an emulsion-induced interfacial anisotropic assembly method, designed for efficient entrapment of PTX and pH-responsive release behaviour. Results: The nano-bowls depicted a typical bowl-like shape, with connecting mesoporous channels and a central hollow cavity, allowing optimal loading of PTX. The fabricated nanocarrier system, mPDA-PTX-nb, had a mean hydrodynamic bowl diameter of 200.4 ± 5.2 nm and a surface charge of −39.2 ± 1.3 mV. The entrapment efficiency of PTX within the nano-bowls was found to be 95.7%, with a corresponding release of 85.1% achieved at the acidic pH 5.9 (simulated tumour microenvironment) at 48 h. Drug release was best fitted to the Peppas–Sahlin model, indicating the involvement of both diffusion and relaxation mechanisms. Treatment with mPDA-PTX-nb significantly suppressed A549 lung cancer cell proliferation at 48 and 72 h, resulting in cell viability of 14.0% and 9.3%, respectively, at the highest concentration (100 µg/mL). Conclusions: These results highlight the potential of mPDA-PTX-nb as an effective nanocarrier for PTX, promoting enhanced anti-proliferative effects in NSCLC therapy.Keywords
Funding Information
- National Institutes of Health (R01CA239042)
- National Research Foundation (NRF) of South Africa (R01CA239042)
This publication has 40 references indexed in Scilit:
- Quality by design fostered fabrication of cabazitaxel loaded pH-responsive Improved nanotherapeutics against prostate cancerColloids and Surfaces B: Biointerfaces, 2023
- Mesoporous Polydopamine Nanobowls Toward Combined Chemo‐ and Photothermal Cancer TherapyParticle & Particle Systems Characterization, 2022
- Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based studyEBioMedicine, 2022
- Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systemsEmergent Materials, 2022
- A novel self-coated polydopamine nanoparticle for synergistic photothermal-chemotherapyColloids and Surfaces B: Biointerfaces, 2021
- Breakthrough in targeted therapy for non-small cell lung cancerBiomedicine & Pharmacotherapy, 2021
- Efficient Cellular Internalization and Transport of Bowl‐Shaped Polydopamine ParticlesParticle & Particle Systems Characterization, 2020
- Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapyActa Biomaterialia, 2018
- A PEG-Fmoc conjugate as a nanocarrier for paclitaxelBiomaterials, 2014
- A simple equation for description of solute release II. Fickian and anomalous release from swellable devicesJournal of Controlled Release, 1987